Report: Walgreens CFO says company is ‘better’ without Express Scripts
NANTUCKET, Mass. — Walgreens CFO Wade Miquelon said that the chain’s decision to break its ties with pharmacy benefit manager Express Scripts was the best decision, according to a Reuters report.
Caling it a "principled stand," Miquelon, who spoke at the Jefferies 2011 Global Consumer Conference in Nantucket, Mass., on Thursday, said that "under any scenario of what Express Scripts is proposing … it’s much better for us to go it alone," Reuters reported.
As previously reported by Drug Store News, Walgreens no longer will participate in the Express Scripts network beginning Jan. 1, 2012, citing unsuccessful renewal negotiations. Express Scripts processes approximately 90 million prescriptions that are expected to be filled by Walgreens in fiscal 2011, representing approximately $5.3 billion in annual sales.
Analysts have theorized that the issues will be settled.
Chris Noth tapped as ambassador for Ask.Screen.Know.
PRINCETON, N.J. — Novo Nordisk has teamed up with actor Chris Noth to underscore the importance of early diabetes screening and detection.
Noth will serve as an ambassador for the national education program Ask.Screen.Know., Novo Nordisk said. As an ambassador, Noth will encourage Americans ages 45 years or older to get tested for diabetes and talk to a healthcare professional about the risk factors through a public service announcement and online at AskScreenKnow.com.
"As reinforced by the latest [Centers for Disease Control] analysis, the diabetes epidemic will continue to be a serious public health issue if we do not make significant changes," Novo Nordisk global chief medical officer Alan Moses said. "The goal of Ask.Screen.Know. is to reduce the burden of diabetes by encouraging those who are at risk for Type 2 diabetes to get tested. If caught early, serious health complications can be prevented or delayed."
Report: FICO develops Medication Adherence Score
NEW YORK — A company best known for keeping credit scores on consumers is planning to rate their medication adherence as well, according to published reports.
The New York Times reported that FICO developed the FICO Medication Adherence Score, designed to predict when patients might not use their medications properly or take their doses. Payers will use the scores, based on such data as homeownership and employment, to determine which patients should receive various reminders to take their drugs.
Medication nonadherence is considered a nationwide health crisis, costing the U.S. healthcare system an estimated $290 billion per year. According to the National Consumers League, three-fourths of Americans taking prescription drugs are not adherent to their medication regimens.